Paula A. Johnson
Director · Maze Therapeutics, Inc.
Individual
- 2026
- Aug 17, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paula A. Johnson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
- Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
- Atul Dandekar - $2.27M in MAZE purchases and sales in the last 12 months
- Catherine A. Sohn - $1.15M in MAZE purchases and sales in the last 12 months
- Amy Bachrodt - $757K in MAZE purchases and sales in the last 12 months
- Phillips Courtney - $105K in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paula A. Johnson?
Paula A. Johnson is a corporate insider, tracked as Director of Maze Therapeutics, Inc. (MAZE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paula A. Johnson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.